SUVRETTA CAPITAL MANAGEMENT, LLC
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1569064
New York, NY
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$95,994,172
+$18,979,474 QoQ
Shares Held
4,768,712
0.0% QoQ
Ownership
8.96%
of shares outstanding
% of Portfolio
2.63%
of 13F equity value
Holder Rank
#3
of 182 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SUVRETTA CAPITAL MANAGEMENT, LLC holds $2,459,096,047 across 36 Biotechnology names. KALV ranks #12 (3.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ARQT |
Arcutis Biotherapeutics, Inc.
|
12,327,000 | $290,424,120 | |
| 2 | MANE |
Veradermics, Inc
|
4,168,970 | $263,270,455 | |
| 3 | PVLA |
Palvella Therapeutics, Inc.
|
1,153,496 | $143,783,276 | |
| 4 | APLS |
Apellis Pharmaceuticals, Inc.
|
3,518,471 | $141,548,088 | |
| 5 | LEGN |
Legend Biotech Corp
|
7,581,029 | $137,140,814 | |
| 6 | BNTC |
Benitec Biopharma Inc.
|
11,548,351 | $122,989,938 | |
| 7 | CAPR |
Capricor Therapeutics, Inc.
|
3,818,600 | $116,085,440 | |
| 8 | IMTX |
Immatics N.V.
|
11,190,129 | $110,110,869 |
All Filings in KALV
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $95,994,172 | 4,768,712 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $77,014,698 | 4,768,712 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $58,082,912 | 4,768,712 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $56,016,275 | 4,955,000 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,696,158 | 4,913,012 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $41,613,211 | 4,913,012 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $48,775,017 | 4,212,005 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $49,381,818 | 4,192,005 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $49,717,179 | 4,192,005 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $32,879,061 | 2,684,005 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $23,312,795 | 2,420,851 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $18,310,554 | 2,034,506 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $15,587,786 | 1,983,179 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $7,248,761 | 1,072,302 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $24,770,021 | 1,707,100 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $18,973,488 | 1,928,200 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $25,740,462 | 1,746,300 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $23,103,549 | 1,746,300 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $26,930,305 | 1,543,284 | Shares | Sole | 2021-11-16 | |
| 2021-06-30 | $28,538,779 | 1,191,101 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $24,659,625 | 959,892 | Shares | Sole | 2021-05-17 | |
| 2020-12-31 | $5,866,011 | 308,900 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $3,889,051 | 308,900 | Shares | Sole | 2020-11-16 | |
| 2020-06-30 | $2,988,700 | 247,000 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $873,630 | 114,200 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||